Source: Picante Today

NantHealth: NantHealth Presented Clinical Data on Immunotherapy, Molecularly Targeted Agents and Tumor Biology at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program

Findings presented during the developmental therapeutics session at the ASCO 2020 Virtual Scientific Program CULVER CITY, Calif.-(BUSINESS WIRE)-NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced the publication of four abstracts on developmental therapeutics for immunotherapy, molecularly targeted agents and tumor biology during the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific [...]

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Patrick Soon-Shiong's photo - Chairman & CEO of NantHealth

Chairman & CEO

Patrick Soon-Shiong

CEO Approval Rating

89/100

NantHealth is a cloud-based medical Information Technology platform that enables medical professionals to share and deliver healthcare information. Read more